374 related articles for article (PubMed ID: 26771888)
1. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
2. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
3. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
4. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.
Murtola TJ; Gurel B; Umbehr M; Lucia MS; Thompson IM; Goodman PJ; Kristal AR; Parnes HL; Lippman SM; Sutcliffe S; Peskoe SB; Barber JR; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):463-9. PubMed ID: 26715424
[TBL] [Abstract][Full Text] [Related]
6. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
[TBL] [Abstract][Full Text] [Related]
7. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
8. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Dluzniewski PJ; Wang MH; Zheng SL; De Marzo AM; Drake CG; Fedor HL; Partin AW; Han M; Fallin MD; Xu J; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1774-82. PubMed ID: 22859398
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.
Platz EA; Kulac I; Barber JR; Drake CG; Joshu CE; Nelson WG; Lucia MS; Klein EA; Lippman SM; Parnes HL; Thompson IM; Goodman PJ; Tangen CM; De Marzo AM
Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1549-1557. PubMed ID: 28754796
[No Abstract] [Full Text] [Related]
10. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Tang L; Platek ME; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JKV; Santella RM; Hsing A; Figg WD; Lippman SM; Thompson IM; Ambrosone CB
Carcinogenesis; 2018 Feb; 39(2):125-133. PubMed ID: 29228205
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.
Gurel B; Lucia MS; Thompson IM; Goodman PJ; Tangen CM; Kristal AR; Parnes HL; Hoque A; Lippman SM; Sutcliffe S; Peskoe SB; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):847-56. PubMed ID: 24748218
[TBL] [Abstract][Full Text] [Related]
12. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.
Tsilidis KK; Helzlsouer KJ; Smith MW; Grinberg V; Hoffman-Bolton J; Clipp SL; Visvanathan K; Platz EA
Cancer Causes Control; 2009 Nov; 20(9):1739-51. PubMed ID: 19760027
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.
Huang BZ; Tsilidis KK; Smith MW; Hoffman-Bolton J; Visvanathan K; Platz EA; Joshu CE
Mol Carcinog; 2018 Oct; 57(10):1278-1288. PubMed ID: 29802748
[TBL] [Abstract][Full Text] [Related]
14. Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.
Nash SH; Schenk JM; Kristal AR; Goodman PJ; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Song X; Gurel B; De Marzo A; Platz EA
Cancer Prev Res (Phila); 2015 Jul; 8(7):590-6. PubMed ID: 25926387
[TBL] [Abstract][Full Text] [Related]
15. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
[TBL] [Abstract][Full Text] [Related]
16. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
17. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial.
Chadid S; Song X; Schenk JM; Gurel B; Lucia MS; Thompson IM; Neuhouser ML; Goodman PJ; Parnes HL; Lippman SM; Nelson WG; De Marzo AM; Platz EA
Nutr Cancer; 2022; 74(1):141-148. PubMed ID: 33511883
[TBL] [Abstract][Full Text] [Related]
20. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
